Novel oncoprotein EPS8: A new target for anticancer therapy

Future Oncology

Volumn 9, Issue 10, 2013, Pages 1587-1594

  Li, Yu Hua ^a   Xue, Tong Yuan ^b   He, Ying Zhi ^a   Du, Jing Wen ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

biomarker; cancer; EPS8; metastasis; migration; oncoprotein; prognosis; proliferation; therapeutic target; tumorigenesis

Indexed keywords

ACTIN CAPPING PROTEIN; BINDING PROTEIN; CISPLATIN; CYCLIN D1; GELATINASE B; ONCOPROTEIN; PACLITAXEL; PHOSPHOLIPID; PROTEIN EPS8; PROTEIN TYROSINE KINASE; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; STAT3 PROTEIN; TRASTUZUMAB; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ANGIOGENESIS; BREAST CANCER; CANCER CELL CULTURE; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL TRANSFORMATION; CHROMOSOME 12P; CHROMOSOME ANALYSIS; COLON CANCER; EXTRACELLULAR MATRIX; FIBROBLAST; FOCAL ADHESION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HYPOPHYSIS TUMOR; METASTASIS; MOUTH SQUAMOUS CELL CARCINOMA; OLIGOMERIZATION; OVARY CANCER; OVERALL SURVIVAL; PANCREAS CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; PROTEIN TARGETING; REVIEW; STOMACH CANCER; STRUCTURE ACTIVITY RELATION; THYROID CANCER; THYROID CARCINOMA; TRANSACTIVATION; TRANSCRIPTION INITIATION; TUMOR GROWTH; UPREGULATION; UTERINE CERVIX CANCER;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTINEOPLASTIC AGENTS; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MOLECULAR TARGETED THERAPY; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; ONCOGENE PROTEINS; SIGNAL TRANSDUCTION;

EID: 84885612339     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.13.104     Document Type: Review

References (65)

1. Castagnino P, Biesova Z, Wong WT, Fazioli F, Gill GN, Di Fiore PP. Direct binding of EPS8 to the juxtamembrane domain of EGFR is phosphotyrosine- and SH2-independent. Oncogene 10(4), 723-729 (1995
2. Fazioli F, Minichiello L, Matoska V et al. EPS8, a substrate for the epidermal growth factor receptor kinase, enhances EGF-dependent mitogenic signals. EMBO J. 12(10), 3799-3808 (1993 (Pubitemid 23282756)
3. Maa MC, Hsieh CY, Leu TH. Overexpression of p97EPS8 leads to cellular transformation: implication of pleckstrin homology domain in p97EPS8-mediated ERK activation. Oncogene 20(1), 106-112 (2001
4. Ion A, Crosby AH, Kremer H et al. Detailed mapping, mutation analysis, and intragenic polymorphism identification in candidate Noonan syndrome genes MYL2, DCN, EPS8, and RPL6. J. Med. Genet. 37(11), 884-886 (2000
5. Wang W, Wyckoff JB, Frohlich VC et al. Single cell behavior in metastatic primary mammary tumors correlated with gene expression patterns revealed by molecular profiling. Cancer Res. 62(21), 6278-6288 (2002 (Pubitemid 35244482)
6. Chen YJ, Shen MR, Maa MC, Leu TH. Eps8 decreases chemosensitivity and affects survival of cervical cancer patients. Mol. Cancer Ther. 7(6), 1376-1385 (2008
7. Maa MC, Lee JC, Chen YJ et al. Eps8 facilitates cellular growth and motility of colon cancer cells by increasing the expression and activity of focal adhesion kinase. J. Biol. Chem. 282(27), 19399-19409 (2007
8. Chu PY, Liou JH, Lin YM et al. Expression of Eps8 correlates with poor survival in oral squamous cell carcinoma. Asia Pac. J. Clin. Oncol. 8(4) e77-e81 (2012
9. Huang Y, Prasad M, Lemon WJ et al. Gene expression in papillary thyroid carcinoma reveals highly consistent profiles. Proc. Natl Acad. Sci. USA 98(26), 15044-15049 (2001 (Pubitemid 34013966)
10. Xu M, Shorts-Cary L, Knox AJ, Kleinsmidt-Demasters B, Lillehei K, Wierman ME. Epidermal growth factor receptor pathway substrate 8 is overexpressed in human pituitary tumors: role in proliferation and survival. Endocrinology 150(5), 2064-2071 (2009
11. Welsch T, Endlich K, Giese T, Buchler MW, Schmidt J. Eps8 is increased in pancreatic cancer and required for dynamic actin-based cell protrusions and intercellular cytoskeletal organization. Cancer Lett. 255(2), 205-218 (2007 (Pubitemid 47268639)
12. Kang H, Wilson CS, Harvey RC et al. Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study. Blood 119(8), 1872-1881 (2012
13. Matoskova B, Wong WT, Salcini AE, Pelicci PG, Di Fiore PP. Constitutive phosphorylation of eps8 in tumor cell lines: relevance to malignant transformation. Mol. Cell Biol. 15(7), 3805-3812 (1995
14. Tocchetti A, Confalonieri S, Scita G, Di Fiore PP, Betsholtz C. In silico analysis of the EPS8 gene family: genomic organization, expression profile, and protein structure. Genomics 81(2), 234-244 (2003 (Pubitemid 36298615)
15. Prieto-Echague V, Chan PM, Craddock BP, Manser E, Miller WT. PTB domain-directed substrate targeting in a tyrosine kinase from the unicellular choanoflagellate Monosiga brevicollis. PLoS One 6(4), e19296 (2011
16. Di Fiore PP, Scita G. EPS8 in the midst of GTPases. Int. J. Biochem. Cell Biol. 34(10), 1178-1183 (2002). n Focuses on EPS8, involved in the control of actin dynamics and of receptor-mediated internalization. (Pubitemid 34804353)
17. Funato Y, Terabayashi T, Suenaga N, Seiki M, Takenawa T, Miki H. IRSp53/Eps8 complex is important for positive regulation of Rac and cancer cell motility/invasiveness. Cancer Res. 64(15), 5237-5244 (2004 (Pubitemid 39006543)
18. Disanza A, Mantoani S, Hertzog M et al. Regulation of cell shape by Cdc42 is mediated by the synergic actin-bundling activity of the Eps8-IRSp53 complex. Nat. Cell Biol. 8(12), 1337-1347 (2006 (Pubitemid 44835108)
19. Slupsky CM, Gentile LN, Donaldson LW et al. Structure of the Ets-1 pointed domain and mitogen-activated protein kinase phosphorylation site. Proc. Natl Acad. Sci. USA 95(21), 12129-12134 (1998 (Pubitemid 28483730)
20. Kishan KV, Newcomer ME, Rhodes TH, Guilliot SD. Effect of pH and salt bridges on structural assembly: molecular structures of the monomer and intertwined dimer of the Eps8 SH3 domain. Protein Sci. 10(5), 1046-1055 (2001 (Pubitemid 32367496)
21. Scita G, Nordstrom J, Carbone R et al. EPS8 and E3B1 transduce signals from Ras to Rac. Nature 401(6750), 290-293 (1999
22. Lanzetti L, Rybin V, Malabarba MG et al. The Eps8 protein coordinates EGF receptor signalling through Rac and trafficking through Rab5. Nature 408(6810), 374-377 (2000
23. Matoskova B, Wong WT, Seki N et al. RN-tre identifies a family of tre-related proteins displaying a novel potential protein binding domain. Oncogene 12(12), 2563-2571 (1996 (Pubitemid 26237785)
24. Shi X, Betzi S, Lugari A et al. Structural recognition mechanisms between human Src homology domain 3 (SH3) and ALG-2-interacting protein X (Alix). FEBS Lett. 586(13), 1759-1764 (2012
25. Inobe M, Katsube K, Miyagoe Y, Nabeshima Y, Takeda S. Identification of EPS8 as a Dvl1-associated molecule. Biochem. Biophys. Res. Commun. 266(1), 216-221 (1999 (Pubitemid 30028794)
26. Mongioví AM, Romano PR, Panni S et al. A novel peptide-SH3 interaction. EMBO J. 18(19), 5300-5309 (1999 (Pubitemid 29465580)
27. Jorissen RN, Walker F, Pouliot N, Garrett TP, Ward CW, Burgess AW. Epidermal growth factor receptor: mechanisms of activation and signalling. Exp. Cell Res. 284(1), 31-53 (2003 (Pubitemid 36331965)
28. Scita G, Tenca P, Areces LB et al. An effector region in Eps8 is responsible for the activation of the Rac-specific GEF activity of Sos-1 and for the proper localization of the Rac-based actin-polymerizing machine. J. Cell Biol. 154(5), 1031-1044 (2001 (Pubitemid 34286182)
29. Disanza A, Carlier MF, Stradal TE et al. Eps8 controls actin-based motility by capping the barbed ends of actin filaments. Nat. Cell Biol. 6(12), 1180-1188 (2004 (Pubitemid 39625116)
30. Offenhauser N, Borgonovo A, Disanza A et al. The eps8 family of proteins links growth factor stimulation to actin reorganization generating functional redundancy in the Ras/Rac pathway. Mol. Biol. Cell 15(1), 91-98 (2004 (Pubitemid 38044946)
31. Yao J, Weremowicz S, Feng B et al. Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression. Cancer Res. 66(8), 4065-4078 (2006
32. Griffith OL, Melck A, Jones SJ, Wiseman SM. Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers. J. Clin. Oncol. 24(31), 5043-5051 (2006 (Pubitemid 46631408)
33. Chen H, Wu X, Pan ZK, Huang S. Integrity of SOS1/EPS8/ABI1 tri-complex determines ovarian cancer metastasis. Cancer Res. 70(23), 9979-9990 (2010
34. Wang H, Teh MT, Ji Y et al. EPS8 upregulates FOXM1 expression, enhancing cell growth and motility. Carcinogenesis 31(6), 1132-1141 (2010
35. Henson ES, Gibson SB. Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: implications for cancer therapy. Cell Signal. 18(12), 2089-2097 (2006 (Pubitemid 44642342)
36. Franke TF, Kaplan DR, Cantley LC, Toker A. Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science 275(5300), 665-668 (1997 (Pubitemid 27061333)
37. Frech M, Andjelkovic M, Ingley E, Reddy KK, Falck JR, Hemmings BA. High affinity binding of inositol phosphates and phosphoinositides to the pleckstrin homology domain of RAC/protein kinase B and their influence on kinase activity. J. Biol. Chem. 272(13), 8474-8481 (1997 (Pubitemid 27147810)
38. Klippel A, Kavanaugh WM, Pot D, Williams LT. A specific product of phosphatidylinositol 3-kinase directly activates the protein kinase Akt through its pleckstrin homology domain. Mol. Cell Biol. 17(1), 338-344 (1997 (Pubitemid 26425623)
39. Costa RH. FoxM1 dances with mitosis. Nat. Cell Biol. 7(2), 108-110 (2005 (Pubitemid 40268125)
40. Laoukili J, Kooistra MR, Bras A et al. FoxM1 is required for execution of the mitotic programme and chromosome stability. Nat. Cell Biol. 7(2), 126-136 (2005 (Pubitemid 40268127)
41. Wang H, Patel V, Miyazaki H, Gutkind JS, Yeudall WA. Role for EPS8 in squamous carcinogenesis. Carcinogenesis 30(1), 165-174 (2009
42. Li Q, Zhang N, Jia Z et al. Critical role and regulation of transcription factor FoxM1 in human gastric cancer angiogenesis and progression. Cancer Res. 69(8), 3501-3509 (2009
43. Schaller MD, Borgman CA, Parsons JT. Autonomous expression of a noncatalytic domain of the focal adhesion-associated protein tyrosine kinase pp125FAK. Mol. Cell Biol. 13(2), 785-791 (1993 (Pubitemid 23040243)
44. Hanks SK, Calalb MB, Harper MC, Patel SK. Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin. Proc. Natl Acad. Sci. USA 89(18), 8487-8491 (1992
45. Leu TH, Yeh HH, Huang CC, Chuang YC, Su SL, Maa MC. Participation of p97Eps8 in Src-mediated transformation. J. Biol. Chem. 279(11), 9875-9881 (2004
46. Maa MC, Lai JR, Lin RW, Leu TH. Enhancement of tyrosyl phosphorylation and protein expression of eps8 by v-Src. Biochem. Biophys. Acta 1450(3), 341-351 (1999
47. Sachdev S, Bu Y, Gelman IH. Paxillin-Y118 phosphorylation contributes to the control of Src-induced anchorage-independent growth by FAK and adhesion. BMC Cancer 9, 12 (2009
48. Parsons JT. Focal adhesion kinase: the first ten years. J. Cell Sci. 116(Pt 8), 1409-1416 (2003 (Pubitemid 36527488)
49. Hanks SK, Ryzhova L, Shin NY, Brabek J. Focal adhesion kinase signaling activities and their implications in the control of cell survival and motility. Front Biosci. 8, d982-d996 (2003 (Pubitemid 38943176)
50. Hertzog M, Milanesi F, Hazelwood L et al. Molecular basis for the dual function of Eps8 on actin dynamics: bundling and capping. PLoS Biol. 8(6), e1000387 (2010
51. Mcgough AM, Staiger CJ, Min JK, Simonetti KD. The gelsolin family of actin regulatory proteins: modular structures, versatile functions. FEBS Lett. 552(2-3), 75-81 (2003 (Pubitemid 37186837)
52. Littlefield R, Fowler VM. Defining actin filament length in striated muscle: rulers and caps or dynamic stability? Annu. Rev. Cell Dev. Biol. 14, 487-525 (1998 (Pubitemid 29001462)
53. Raftopoulou M, Hall A. Cell migration: Rho GTPases lead the way. Dev. Biol. 265(1), 23-32 (2004 (Pubitemid 38018819)
54. Innocenti M, Tenca P, Frittoli E et al. Mechanisms through which Sos-1 coordinates the activation of Ras and Rac. J. Cell Biol. 156(1), 125-136 (2002). nn Illustrated the role of Sos-1 in the signaling pathway leading to activation of Rac. (Pubitemid 34846941)
55. Mitra S, Lee JS, Cantrell M, Van den Berg CL. c-Jun N-terminal kinase 2 (JNK2) enhances cell migration through epidermal growth factor substrate 8 (EPS8). J. Biol. Chem. 286(17), 15287-15297 (2011
56. Frittoli E, Matteoli G, Palamidessi A et al. The signaling adaptor Eps8 is an essential actin capping protein for dendritic cell migration. Immunity 35(3), 388-399 (2011). n Identifies EPS8 as a unique actin-capping protein, specifically required for dendritic cell migration.
57. Miyazaki H, Patel V, Wang H, Edmunds RK, Gutkind JS, Yeudall WA. Down-regulation of CXCL5 inhibits squamous carcinogenesis. Cancer Res. 66(8), 4279-4284 (2006
58. Liotta LA. Tumor invasion and metastases - role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Res. 46(1), 1-7 (1986 (Pubitemid 16189019)
59. Yap LF, Jenei V, Robinson CM et al. Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation. Oncogene 28(27), 2524-2534 (2009
60. Bates RC, Bellovin DI, Brown C et al. Transcriptional activation of integrin b6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. J. Clin Invest. 115(2), 339-347 (2005 (Pubitemid 40385475)
61. Elayadi AN, Samli KN, Prudkin L et al. A peptide selected by biopanning identifies the integrin avb6 as a prognostic biomarker for nonsmall cell lung cancer. Cancer Res. 67(12), 5889-5895 (2007 (Pubitemid 46985024)
62. Yang TP, Chiou HL, Maa MC, Wang CJ. Mithramycin inhibits human epithelial carcinoma cell proliferation and migration involving downregulation of Eps8 expression. Chem. Biol. Interact. 183(1), 181-186 (2010
63. Boran AD. The regulatory role of the juxtamembrane region in the activity of the epidermal growth factor receptor. Biochem. Soc. Trans. 40(1), 195-199 (2012). n Highlights the role of the juxtamembrane domain in EGFR activation.
64. Pegram M, Ngo D. Application and potential limitations of animal models utilized in the development of trastuzumab (Herceptin): a case study. Adv. Drug Deliv. Rev. 58(5-6), 723-734 (2006 (Pubitemid 44247227)
65. Ono M, Hirata A, Kometani T et al. Sensitivity to gefitinib (Iressa, ZD1839) in non-small cell lung cancer cell lines correlates with dependence on the epidermal growth factor (EGF) receptor/extracellular signal-regulated kinase 1/2 and EGF receptor/Akt pathway for proliferation. Mol. Cancer Ther. 3(4), 465-472 (2004).